Latest stories on CGTX
Cognition Therapeutics Advances Zervimesine Toward Phase 3 DLB Trial
TipRanks58 · neutralproduct/pr
Is Cognition Therapeutics, Inc. (CGTX) Moving Closer to a Registrational Trial in Dementia With Lewy Bodies?
Yahoo Top58 · neutralproduct/pr
Cognition Therapeutics Participating in Upcoming Investor Conferences | CGTX Stock News
StockTitan53 · neutralproduct/pr